Concepedia

Griffin Budde

GB

Statistics

Publications

4

Citations

157

H-Index

4

Active since

2022

Affiliations

Natera (United States)(Current)

Weill Cornell Medicine

Presbyterian Hospital

New York Hospital Queens

Cornell University

Griffin Budde is an author at Natera (United States) specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2022–2024

4

Publications

4

Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers

Brandon M. Huffman, Vasily N. Aushev, Griffin Budde et al. · JCO Precision Oncology · 2022 · 73 citations · Full text

, , +17

Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer

Pashtoon Murtaza Kasi, Griffin Budde, Michael Krainock et al. · Journal for ImmunoTherapy of Cancer · 2022 · 45 citations · Full text

, , +17

Early real-world experience monitoring circulating tumor DNA in resected early-stage non–small cell lung cancer

Travis K. Martin, Aaron J Dinerman, Sumedha Sudhaman et al. · Journal of Thoracic and Cardiovascular Surgery · 2024 · 20 citations

, , +14

Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma

Elise K. Brunsgaard, Tawnya L. Bowles, Elliot A. Asare et al. · Melanoma Research · 2023 · 19 citations · Full text

, , +17

1–4 of 4